Get the Stockscreener App
9.841
2.72%
-0.279
Fortrea Holdings Inc stock is traded at $9.841, with a volume of 955.58K.
It is down -2.72% in the last 24 hours and up +4.18% over the past month.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
See More
Previous Close:
$10.12
Open:
$9.79
24h Volume:
955.58K
Relative Volume:
0.62
Market Cap:
$893.47M
Revenue:
$2.98B
Net Income/Loss:
$-300.00M
P/E Ratio:
-2.8944
EPS:
-3.4
Net Cash Flow:
$225.00M
1W Performance:
-7.30%
1M Performance:
+4.18%
6M Performance:
+57.27%
1Y Performance:
-41.64%
1-Day Range:
$9.52
$9.90
1-Week Range:
$9.52
$10.91
52-Week Range:
$3.97
$25.28
Fortrea Holdings Inc Stock (FTRE) Company Profile
Name
Fortrea Holdings Inc
Sector
Industry
Phone
877-495-0816
Address
8 MOORE DRIVE, DURHAM
Compare FTRE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FTRE
Fortrea Holdings Inc
|
9.84 | 918.90M | 2.98B | -300.00M | 225.00M | -3.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.98 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
627.75 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.31 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
835.62 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.72 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-04-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-02-25 | Initiated | Truist | Hold |
| Apr-10-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-06-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-25-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-08-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-24-24 | Resumed | Barclays | Equal Weight |
| Jun-06-24 | Initiated | Goldman | Neutral |
| May-29-24 | Initiated | TD Cowen | Hold |
| May-28-24 | Initiated | Mizuho | Neutral |
| Mar-22-24 | Initiated | Robert W. Baird | Neutral |
| Mar-06-24 | Initiated | Deutsche Bank | Hold |
| Jan-05-24 | Initiated | William Blair | Mkt Perform |
| Jan-04-24 | Initiated | Jefferies | Buy |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Dec-01-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-14-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-19-23 | Initiated | Citigroup | Neutral |
| Sep-14-23 | Initiated | Evercore ISI | In-line |
| Aug-16-23 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Initiated | BofA Securities | Underperform |
View All
Fortrea Holdings Inc Stock (FTRE) Latest News
Is Fortrea Holdings Inc. stock a buy before product launches2025 Volume Leaders & High Conviction Investment Ideas - newser.com
Is Fortrea Holdings Inc. stock attractive for ETFs2025 Geopolitical Influence & Daily Chart Pattern Signals - newser.com
Will Fortrea Holdings Inc. (K67) stock benefit from sector leadership2025 Breakouts & Breakdowns & Safe Investment Capital Preservation Plans - newser.com
Will Fortrea Holdings Inc. (K67) stock extend growth storyEarnings Miss & Low Risk High Reward Ideas - newser.com
Fortrea (FTRE) Reports Q3: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Can Fortrea Holdings Inc. (K67) stock sustain revenue momentum2025 AllTime Highs & Technical Analysis for Trade Confirmation - newser.com
Multi asset correlation models including Fortrea Holdings Inc.Breakout Watch & Advanced Swing Trade Entry Plans - newser.com
What institutional flow reveals about Fortrea Holdings Inc.2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Using economic indicators to assess Fortrea Holdings Inc. potential2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - newser.com
MUFG Securities EMEA plc Invests $2.41 Million in Fortrea Holdings Inc. $FTRE - MarketBeat
Will earnings trigger a reversal in Fortrea Holdings Inc.GDP Growth & Pattern Based Trade Signal System - newser.com
Advanced analytics toolkit walkthrough for Fortrea Holdings Inc.Quarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com
Momentum divergence signals in Fortrea Holdings Inc. chartQuarterly Market Summary & Risk Controlled Daily Trade Plans - newser.com
What drives Fortrea Holdings Inc stock priceCurrency Fluctuation Impact & Double Or Triple Investment - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings, Inc. (FTRE) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Why The Narrative Around Fortrea Holdings Is Shifting Amid New Analyst and Business Updates - Yahoo Finance
How Fortrea Holdings Inc. stock performs in high volatility markets2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
31,616 Shares in Fortrea Holdings Inc. $FTRE Bought by Brighton Jones LLC - MarketBeat
Is Fortrea Holdings Inc. (K67) stock a contrarian opportunity2025 Institutional Moves & Weekly High Return Stock Forecasts - newser.com
Is Fortrea Holdings Inc. stock a buy for dividend growthTrade Ideas & Verified Technical Trade Signals - newser.com
Fortrea Reports Second Quarter 2025 Results - ADVFN
Mutual of America Capital Management LLC Has $57,000 Holdings in Fortrea Holdings Inc. $FTRE - MarketBeat
Fortrea Holdings Inc. (FTRE) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Fortrea and GE Healthcare’s New Diagnostic Study: A Potential Game-Changer in Cancer Detection - TipRanks
Fortrea (FTRE) to Release Earnings on Wednesday - MarketBeat
Fortrea’s New Clinical Trial: A Game Changer in Spinal Surgery? - MSN
Fortrea Holdings Inc. (FTRE) Stock forecasts - Yahoo! Finance UK
Fortrea Holdings Inc. (FTRE) Stock Forecasts - Yahoo! Finance Canada
Fortrea’s Givinostat Study: A New Hope for Young DMD Patients - TipRanks
What drives Fortrea Holdings Inc K67 stock priceTechnical Resistance Breaks & Plan Your Exit as You Enter – Risk First - earlytimes.in
Exploring October 2025's Top Undervalued Small Caps With Insider Activity - simplywall.st
Fortrea Holdings Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
Fortrea’s Givinostat Study: A Potential Game-Changer for Duchenne Muscular Dystrophy - MSN
Fortrea Holdings Inc Stock (FTRE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.86%
0.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):